Abstract | AIM: To study the antitumor mechanism of 3-substituted aryl oxindole (PH II-7) and determine its effects on cell cycle distribution of tumor cells. METHODS: The cell cycle distributions were determined with FACS. The cell cycle regulation-related proteins of K562 lysates were analyzed with Western Blot. The inhibition of PH II-7 on DNA synthesis of tumor cells were estimated though 3H-thymidine incorporation and the tyrosine kinase activity of EGFR of A431 lysates was measured with ELISA. RESULTS: PH II-7 effected cell cycle distribution of several tumor cells, including multidrug resistant tumor cell lines, and accumulation of cells in the G0-G1 stages was observed. The cell cycle regulation-related proteins CDK2, Rb and c-myc were inhibited by PH II-7 in a dose dependent manner, whereas the expression of CyclinE was increased after exposure to PH II-7. Furthermore, PH II-7 2.0 mg.L-1 was shown to inhibit the incorporation of 3H-thymidine into DNA, and 21.89%-41.29% of the PTK activity of EGFR in A431 lysates was inhibited by PH II-7 2-8 mg.L-1 in a dose-dependant manner. CONCLUSION: PH II-7, a new anti- tumor agent, blocks the transition of cell cycle of tumor cells from G1 to S phase by inhibition CDK2.
|
Authors | Yao-hong Tan, Chun-zheng Yang, Jing Qi, Jin-hong Wang, Cai-yun Wang, Hui Peng |
Journal | Yao xue xue bao = Acta pharmaceutica Sinica
(Yao Xue Xue Bao)
Vol. 38
Issue 11
Pg. 805-8
(Nov 2003)
ISSN: 0513-4870 [Print] China |
PMID | 14991989
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Cell Cycle Proteins
- Cyclin E
- DNA, Neoplasm
- Indoles
- Oxindoles
- Proto-Oncogene Proteins c-myc
- Retinoblastoma Protein
- 2-oxindole
- CDC2-CDC28 Kinases
- CDK2 protein, human
- Cyclin-Dependent Kinase 2
|
Topics |
- Antineoplastic Agents
(pharmacology)
- CDC2-CDC28 Kinases
(metabolism)
- Cell Cycle
(drug effects)
- Cell Cycle Proteins
(metabolism)
- Cyclin E
(metabolism)
- Cyclin-Dependent Kinase 2
- DNA, Neoplasm
(biosynthesis)
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Humans
- Indoles
(chemical synthesis, pharmacology)
- K562 Cells
(pathology)
- Oxindoles
- Proto-Oncogene Proteins c-myc
(metabolism)
- Retinoblastoma Protein
(metabolism)
|